Wenkang Fu
Lanzhou, 730030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity.
Journal: Acta pharmaceutica Sinica. B
Published: April 10, 2025
Real-time diagnosis of cholangiocarcinoma by combining digestive endoscopy and optic fiber biosensors based on bile clusterin.
Journal: Med (New York, N.Y.)
Published: March 19, 2025
Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6.
Journal: Scientific reports
Published: June 27, 2024
Design of the distribution of iron oxide (Fe3O4) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermia.
Journal: Pharmacological research
Published: May 31, 2024
Correction: Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
Journal: BMC medicine
Published: April 28, 2024
Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications.
Journal: Medical review (2021)
Published: March 27, 2024
Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing.
Journal: Acta pharmaceutica Sinica. B
Published: February 20, 2024
Regular use of paracetamol and risk of liver cancer: a prospective cohort study.
Journal: BMC cancer
Published: October 05, 2023
Correction: Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
Journal: BMC medicine
Published: September 29, 2023
Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1.
Journal: Human cell
Published: September 11, 2023
Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic cancer and is associated with B-cell Infiltration in pancreatic cancer.
Journal: Frontiers in oncology
Published: August 25, 2023
Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota.
Journal: Frontiers in pharmacology
Published: May 05, 2023
Last Updated: 09/26/2026